Evidence map›Paper›PMID 31453100›Full record

ArticleIDCases2019

Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole.

Marta Ilharco, Carla Maravilha Pereira, Laura Moreira, Ana Luísa Proença, Maria do Carmo Fevereiro, Fátima Lampreia, Miguel Lopes Oliveira, José Rola

Open access · goldAbstract readCase Reports
In one paragraph

Article in IDCases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Cutaneous Mucormycosis in a Young Immunocompetent Trauma Patient: A Case Report.European journal of case reports in internal medicine · 2023
    Article
  5. COVID-19 associated mucormycosis - An emerging threat.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2022
    Review
  6. Review
  7. Isavuconazole-Animal Data and Clinical Data.Journal of fungi (Basel, Switzerland) · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Marta IlharcoDepartment of Internal Medicine 1.4, Hospital de S. José - Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Carla Maravilha PereiraDepartment of Internal Medicine 1.4, Hospital de S. José - Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Laura MoreiraDepartment of Internal Medicine 1.4, Hospital de S. José - Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Ana Luísa ProençaDepartment of Radiology, Hospital de Curry Cabral - Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Maria do Carmo FevereiroDepartment of Internal Medicine 1.4, Hospital de S. José - Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Fátima LampreiaDepartment of Internal Medicine 1.4, Hospital de S. José - Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Miguel Lopes OliveiraDepartment of Maxillofacial Surgery, Hospital de S. José - Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
José RolaDepartment of Internal Medicine 1.4, Hospital de S. José - Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Hospital de São José · PTHospital Curry Cabral · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucormycosis is a severe opportunistic fungal infection caused by

Indexed as

Hyperbaric oxygenImmunocompetentIsavuconazoleMucormycosis

Identifiers

PMID31453100
PMCPMC6700484
OpenAlexW2956203438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.